Pharma

By  Thiru Gunasegaran 05:52 am June 11, 2021
Pakistani online pharmacy Dawaai has announced that it raised $8.5 million in a recent investing round led by US-based 500 Startups and participated by local venture capital firm Sarmayacar. Kingsway Capital, Crimson Seed Capital and Mentors Fund also participated in the round. WHY IT MATTERS Launched in 2014, Dawaai is touted to be Pakistan's largest pharmaceutical marketplace that offers...
PharmStars founders Naomi Fried and Laura Gunn
By  Laura Lovett 01:20 pm June 1, 2021
The pharma world is notoriously slow moving, taking years to develop a molecule. Meanwhile digital health companies are often working at breakneck speed to innovate. This is just one of the many culture gaps the pair encounter working together, according to digital innovation vet Naomi Fried. This morning, Fried and pharmaceutical exec Laura Gunn announced a new accelerator, dubbed PharmStars, ...
Researcher
By  Naomi Fried and Laura Gunn 10:55 am May 25, 2021
Digital health has the potential to transform the pharmaceutical industry and the patient experience. Both digital health startups and pharma are eager to engage each other. Pharma continues to have significant need to leverage innovative "beyond the pill solutions."  Digital health startups offer a wealth of potential solutions, and investors have noticed. Such startups attracted over $6.7...
Podcast guest John Reites
By  MobiHealthNews 02:03 pm May 21, 2021
The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic. On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura...
Lauri Sippola, CEO of Kaiku, gives a demonstration in his Helsinki office.
By  Laura Lovett 11:25 am April 20, 2021
Kaiku Health, maker of an oncology-focused platform that collected patient-reported outcomes, is teaming up with pharma giant Novartis on a new initiative to help monitor and manage melanoma. The companies will zero in on creating a remote monitoring and support network for patients receiving a specific drug combination, known as BRAF and MEK inhibitors, that aims to treat melanoma. As part of...
NVIDIA research
By  Laura Lovett 10:58 am April 12, 2021
Silicon Valley giant NVIDIA is teaming up with pharma company AstraZeneca and the University of Florida on new artificial intelligence research projects aimed at boosting drug discovery and patient care. This morning NVIDIA and AstraZeneca revealed a new drug-discovery model called MegaMoIBART, which is aimed at "reaction prediction, molecular optimization and de novo molecular generation."...
Deals
By  Laura Lovett 11:56 am April 6, 2021
Digital therapeutics company Pear Therapeutics is looking to integrate digital biomarkers, machine learning algorithms and sensor-based technologies into its platform thanks to new licensing deals and partnerships. The Boston-based DTx company has inked collaboration deals with Empatica and etectRx, as well as licensing tech from KeyWise. Specifically, Pear's collaboration with Empatica will...
Nerve cells affected by Alzheimer's disease
By  Dave Muoio 03:04 pm April 1, 2021
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences. The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
Scientist in lab
By  Laura Lovett 02:19 pm March 31, 2021
Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients. During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsuka's Global Clinical Development on...
By  Dave Muoio 03:26 pm March 23, 2021
Dr. Amy Abernethy, Principal Deputy Commissioner and Acting Chief Information Officer at the FDA, will be stepping down from her positions at the agency in mid-to-late April, according to a memo Acting FDA Commissioner Dr. Janet Woodcock sent out to agency staff this morning. Abernethy came to the agency in early 2019 following a long line of executive and board positions at healthcare and health...